Publications found:
64,029
Sort by:
2018 Primary biliary cirrhosis Drug Development- Pipeline Analysis Report
US$ 899.00
... and universities are focusing on developing treatment options for Primary biliary cirrhosis. To assist investigators and funding and regulatory organizations, ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary biliary cirrhosis pipeline product. Mechanism ...
May 2018
-
2018 Primary billary cholangitis Drug Development- Pipeline Analysis Report
US$ 899.00
... universities are focusing on developing treatment options for Primary billary cholangitis. To assist investigators and funding and regulatory organizations ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary billary cholangitis pipeline product. Mechanism ...
May 2018
-
2018 Primary Sclerosing Cholangitis Drug Development- Pipeline Analysis Report
US$ 899.00
... universities are focusing on developing treatment options for Primary sclerosing cholangitis. To assist investigators and funding and regulatory organizations ... developments, orphan drug/fast track/other designations, drug class are provided for each Primary sclerosing cholangitis pipeline product. Mechanism ...
May 2018
-
2018 Reflux Esophagitis/GERD Drug Development- Pipeline Analysis Report
US$ 899.00
... Around 30 companies and universities are focusing on developing treatment options for Reflux Esophagitis/GERD. To assist investigators and funding and regulatory ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Reflux Esophagitis/GERD pipeline product. ...
May 2018
-
2018 Short Bowel Syndrome Drug Development- Pipeline Analysis Report
US$ 899.00
... and universities are focusing on developing treatment options for Short Bowel Syndrome. To assist investigators and funding and regulatory organizations, ... , recent developments, orphan drug/fast track/other designations, drug class are provided for each Short Bowel Syndrome pipeline product. Mechanism of ...
May 2018
-
2018 Systemic Mastocytosis Drug Development- Pipeline Analysis Report
US$ 899.00
... Around 15 companies and universities are focusing on developing treatment options for Systemic Mastocytosis. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Systemic Mastocytosis pipeline product. ...
May 2018
-
2018 Traveler’s Diarrhea Drug Development- Pipeline Analysis Report
US$ 899.00
... Around 10 companies and universities are focusing on developing treatment options for Traveler's Diarrhea. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Traveler's Diarrhea pipeline product. ...
May 2018
-
2018 Alcoholic Hepatitis Drug Development- Pipeline Analysis Report
US$ 899.00
... and universities are focusing on developing treatment options for Alcoholic Hepatitis. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Alcoholic Hepatitis pipeline product. ...
April 2018
-
2018 Atrial Fibrillation Drug Development- Pipeline Analysis Report
US$ 899.00
... and universities are focusing on developing treatment options for Atrial Fibrillation. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Atrial Fibrillation pipeline product. ...
April 2018
-
2018 Community- Acquired Pneumonia (CAP) Drug Development- Pipeline Analysis Report
US$ 899.00
... myalgia, arthralgia are key symptoms. Community Acquired Pneumonia pipeline comprises of 16 drugs under active development as of April 2018. Of these, 3 drugs are ... has come up with a comprehensive report on Community Acquired Pneumonia (CAP) pipeline. The report provides insights into different therapeutic ...
April 2018
-
2018 Critical Limb Ischemia (CLI) Drug Development- Pipeline Analysis Report
US$ 899.00
... Critical Limb Ischemia worldwide, with an estimated market size of $10 to $12 billion. Critical Limb Ischemia pipeline comprises of 27 active drugs under active development as of April 2018 ... come up with a comprehensive report on Critical Limb Ischemia (CLI) pipeline. The report provides insights into ...
April 2018
-
2018 hepatitis C Drug Development- Pipeline Analysis Report
US$ 899.00
... no vaccine is available against HCV. Due to the mutations in Hepatitis C virus, development of a prophylactic vaccine is highly challenging. The condition is classified ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Hepatitis C (HCV) pipeline ...
April 2018
-
Resistant Hypertension: Drug Development Pipeline Study, H1 2018
US$ 806.00
... . The most comprehensive pipeline review “Resistant Hypertension- Drug Development Pipeline Study” provides in-depth analysis and update information on Resistant Hypertension pipeline drugs. Current status of all the drugs in the Resistant Hypertension pipeline is provided in the ...
March 2018
28 pages
Portal Hypertension: Drug Development Pipeline Study, H1 2018
US$ 806.00
... . The most comprehensive pipeline review “Portal Hypertension- Drug Development Pipeline Study” provides in-depth analysis and update information on Portal Hypertension pipeline drugs. Current status of all the drugs in the Portal Hypertension pipeline is provided in the ...
March 2018
31 pages
Ocular Hypertension: Drug Development Pipeline Study, H1 2018
US$ 806.00
... . The most comprehensive pipeline review “Ocular Hypertension- Drug Development Pipeline Study” provides in-depth analysis and update information on Ocular Hypertension pipeline drugs. Current status of all the drugs in the Ocular Hypertension pipeline is provided in the ...
March 2018
61 pages
Cancer Cachexia: Drug Development Pipeline Study, H1 2018
US$ 806.00
... . The most comprehensive pipeline review “Cancer Cachexia- Drug Development Pipeline Study” provides in-depth analysis and update information on Cancer Cachexia pipeline drugs. Current status of all the drugs in the Cancer Cachexia pipeline is provided in the ...
March 2018
47 pages
Hypoparathyroidism: Drug Development Pipeline Study, H1 2018
US$ 806.00
... that impact the Hypoparathyroidism industry. Excerpts from- “Hypoparathyroidism- Drug Development Pipeline Study”: Hypoparathyroidism pipeline comprises of 6 drugs under development as of February 2018. Of these, 3 drugs are in Phase 1 and 1 drug is in phase 2. Further, 2 drugs remain in Pre ...
February 2018
32 pages
Impetigo: Drug Development Pipeline Study, H1 2018
US$ 806.00
... the Impetigo industry. Excerpts from- “Impetigo- Drug Development Pipeline Study”: Impetigo pipeline comprises of 4 drugs under development as of February 2018. Of these, 2 drugs are in Phase 2 and 1 drug is in phase 2/3. Further, 1 drug is in Pre-Clinical Stage. No drugs have ...
February 2018
22 pages
Pontine Glioma (DIPG):Drug Development Pipeline Study, H1 2018
US$ 806.00
... Diffuse Intrinsic Pontine Glioma (DIPG) industry. Excerpts from- “Diffuse Intrinsic Pontine Glioma (DIPG)- Drug Development Pipeline Study”: Pontine Glioma pipeline comprises of 24 drugs under development as of February 2018. Of these, 6 drugs are in Phase 1 and 3 drugs are in phase ...
February 2018
65 pages
